Background & Aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary
disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of …

OBJECTIVE.: CD24 is an established marker for poor prognosis in ovarian and other
carcinomas. Acquisition of cytoplasmic CD24, as opposed to membranous expression, has been …

OBJECTIVE: Cancer cells in the body release soluble and membranous factors that manipulate
the tumor environment to facilitate growth and survival. Recent years have provided …

Background: Meiosis is the process by which gametes are generated with half the ploidy of
somatic cells. This reduction is achieved by three major differences in chromosome behavior …

Tumor-derived exosomes have been shown to induce various immunomodulatory effects.
However, the underlying signaling pathways are poorly understood. Here, we analyzed the …

MDSCs have been shown to be induced by tumors and suppress antitumor immunity. Here
we show that the gut microbiome can control accumulation of MDSCs in the liver in the …

Activated tumor stroma participates in tumor cell growth, invasion, and metastasis. Normal
fibroblasts and cancer-associated fibroblasts (CAFs) have been shown to display distinct …

Approximately 60%‐80% of patients with primary sclerosing cholangitis (PSC) have concurrent
ulcerative colitis (UC). Previous genome‐wide association studies (GWAS) in PSC have …

Liver transplantation (LT) is the only definitive treatment for patients with end‐stage liver
disease due to primary sclerosing cholangitis (PSC), but a high rate of biliary strictures (BSs) …

We report a case of resistance development toward cefiderocol in a patient with intra-abdominal
and bloodstream infections caused by carbapenemase-producing Enterobacter cloacae …